Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T
Division of Cardiology, Sakurabashi Watanabe Hospital, Osaka, Japan.
Circulation. 1996 Jan 15;93(2):223-8. doi: 10.1161/01.cir.93.2.223.
Recent studies demonstrated that the "no reflow" phenomenon after coronary reflow implies the presence of advanced myocardial damage. In this study, we verified the prognostic value of the detection of this phenomenon by studying complications, left ventricular morphology, and in-hospital survival after acute myocardial infarction (AMI).
The study population consisted of 126 patients with a first anterior AMI. All patients received coronary reflow within 24 hours of onset of symptoms and underwent myocardial contrast echocardiography (MCE) before and shortly after coronary reflow with an intracoronary injection of sonicated microbubbles. From contrast reperfusion patterns, patients were divided into two subsets: those with MCE no reflow (47 patients, 37%) and those with MCE reflow (79 patients). There was no difference in the frequency of arrhythmia or coronary events between the two subsets. Pericardial effusion and early congestive heart failure were observed more frequently in patients with MCE no reflow than in those with MCE reflow (26% versus 4%, P < .05; 45% versus 15%, P < .05, respectively). Congestive heart failure tended to be prolonged in those with MCE no reflow, and 3 patients (7%) of this subset died of pump failure. Left ventricular end-diastolic volume progressively increased in the convalescent stage in patients with MCE no reflow (early versus late, 145 +/- 43 versus 169 +/- 60 mL, P < .001), whereas it decreased in those with MCE reflow (154 +/- 42 versus 144 +/- 44 mL, P < .01).
The substantial size of the MCE no reflow phenomenon at coronary reflow conveys useful information about an outcome of coronary intervention and left ventricular remodeling in individual patients with anterior wall AMI, although these are suggestive results in a limited number of patients.
近期研究表明,冠状动脉再灌注后的“无复流”现象提示存在严重的心肌损伤。在本研究中,我们通过研究急性心肌梗死(AMI)后的并发症、左心室形态及院内生存率,验证了检测该现象的预后价值。
研究人群包括126例首次发生前壁AMI的患者。所有患者在症状发作后24小时内接受冠状动脉再灌注,并在冠状动脉再灌注前后不久经冠状动脉内注射超声微泡进行心肌对比超声心动图(MCE)检查。根据对比剂再灌注模式,患者被分为两个亚组:MCE无复流患者(47例,37%)和MCE复流患者(79例)。两个亚组之间心律失常或冠状动脉事件的发生率无差异。MCE无复流患者心包积液和早期充血性心力衰竭的发生率高于MCE复流患者(分别为26%对4%,P<.05;45%对15%,P<.05)。MCE无复流患者的充血性心力衰竭往往持续时间更长,该亚组中有3例(7%)患者死于泵衰竭。MCE无复流患者在恢复期左心室舒张末期容积逐渐增加(早期对晚期,145±43对169±60 mL,P<.001),而MCE复流患者则减小(154±42对144±44 mL,P<.01)。
冠状动脉再灌注时MCE无复流现象的大小,为前壁AMI个体患者的冠状动脉介入治疗结果和左心室重构提供了有用信息,尽管这些结果是在有限数量患者中得出的提示性结果。